vs
和黄医药(HCM)与WSFS FINANCIAL CORP(WSFS)财务数据对比。点击上方公司名可切换其他公司
WSFS FINANCIAL CORP的季度营收约是和黄医药的1.0倍($275.3M vs $270.8M),WSFS FINANCIAL CORP净利率更高(31.5% vs 0.7%,领先30.8%),WSFS FINANCIAL CORP同比增速更快(7.5% vs -16.5%)
和黄医药是一家国际化生物制药企业,专注于肿瘤、免疫类疾病的靶向疗法与免疫疗法的研发、生产及商业化,核心市场覆盖中国及全球多个国家地区,已有多款肿瘤治疗药物上市,后期临床管线储备丰富。
WSFS金融集团是一家金融服务企业,核心子公司WSFS银行是总部位于特拉华州及大特拉华谷地区规模最大、经营历史最久的本地管理银行与财富管理机构。集团共运营115个网点,其中88个为银行网点,分布在宾夕法尼亚、特拉华、新泽西、佛罗里达、弗吉尼亚、内华达六州,提供全面金融服务。
HCM vs WSFS — 直观对比
营收规模更大
WSFS
是对方的1.0倍
$270.8M
营收增速更快
WSFS
高出24.0%
-16.5%
净利率更高
WSFS
高出30.8%
0.7%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | ||
|---|---|---|
| 营收 | $270.8M | $275.3M |
| 净利润 | $2.0M | $86.8M |
| 毛利率 | 37.7% | — |
| 营业利润率 | -13.2% | — |
| 净利率 | 0.7% | 31.5% |
| 营收同比 | -16.5% | 7.5% |
| 净利润同比 | -83.6% | 31.7% |
| 每股收益(稀释后) | $0.00 | $1.64 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
HCM
WSFS
| Q1 26 | — | $275.3M | ||
| Q4 25 | $270.8M | $271.9M | ||
| Q3 25 | — | $270.5M | ||
| Q2 25 | $277.7M | $267.5M | ||
| Q1 25 | $324.5M | $256.1M | ||
| Q4 24 | — | $261.5M | ||
| Q3 24 | — | $267.7M | ||
| Q2 24 | $305.7M | $266.0M |
净利润
HCM
WSFS
| Q1 26 | — | $86.8M | ||
| Q4 25 | $2.0M | $72.7M | ||
| Q3 25 | — | $76.4M | ||
| Q2 25 | $455.0M | $72.3M | ||
| Q1 25 | $11.9M | $65.9M | ||
| Q4 24 | — | $64.2M | ||
| Q3 24 | — | $64.4M | ||
| Q2 24 | $25.8M | $69.3M |
毛利率
HCM
WSFS
| Q1 26 | — | — | ||
| Q4 25 | 37.7% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.1% | — | ||
| Q1 25 | 48.0% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 41.1% | — |
营业利润率
HCM
WSFS
| Q1 26 | — | — | ||
| Q4 25 | -13.2% | 35.8% | ||
| Q3 25 | — | 37.3% | ||
| Q2 25 | -1.3% | 35.7% | ||
| Q1 25 | -5.0% | 34.0% | ||
| Q4 24 | — | 32.3% | ||
| Q3 24 | — | 31.9% | ||
| Q2 24 | -9.0% | 34.0% |
净利率
HCM
WSFS
| Q1 26 | — | 31.5% | ||
| Q4 25 | 0.7% | 26.7% | ||
| Q3 25 | — | 28.3% | ||
| Q2 25 | 163.8% | 27.0% | ||
| Q1 25 | 3.7% | 25.7% | ||
| Q4 24 | — | 24.6% | ||
| Q3 24 | — | 24.1% | ||
| Q2 24 | 8.4% | 26.0% |
每股收益(稀释后)
HCM
WSFS
| Q1 26 | — | $1.64 | ||
| Q4 25 | $0.00 | $1.33 | ||
| Q3 25 | — | $1.37 | ||
| Q2 25 | $0.52 | $1.27 | ||
| Q1 25 | $0.01 | $1.12 | ||
| Q4 24 | — | $1.08 | ||
| Q3 24 | — | $1.08 | ||
| Q2 24 | $0.03 | $1.16 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $1.4B | — |
| 总债务越低越好 | $93.2M | — |
| 股东权益账面价值 | $1.2B | $2.7B |
| 总资产 | $1.8B | $22.1B |
| 负债/权益比越低杠杆越低 | 0.08× | — |
8季度趋势,按日历期对齐
现金及短期投资
HCM
WSFS
| Q1 26 | — | — | ||
| Q4 25 | $1.4B | $1.7B | ||
| Q3 25 | — | — | ||
| Q2 25 | $1.4B | — | ||
| Q1 25 | $836.1M | — | ||
| Q4 24 | — | $1.2B | ||
| Q3 24 | — | — | ||
| Q2 24 | $802.5M | — |
总债务
HCM
WSFS
| Q1 26 | — | — | ||
| Q4 25 | $93.2M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $93.4M | — | ||
| Q1 25 | $82.8M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $82.1M | — |
股东权益
HCM
WSFS
| Q1 26 | — | $2.7B | ||
| Q4 25 | $1.2B | $2.7B | ||
| Q3 25 | — | $2.8B | ||
| Q2 25 | $1.2B | $2.7B | ||
| Q1 25 | $759.9M | $2.7B | ||
| Q4 24 | — | $2.6B | ||
| Q3 24 | — | $2.7B | ||
| Q2 24 | $740.1M | $2.5B |
总资产
HCM
WSFS
| Q1 26 | — | $22.1B | ||
| Q4 25 | $1.8B | $21.3B | ||
| Q3 25 | — | $20.8B | ||
| Q2 25 | $1.8B | $20.8B | ||
| Q1 25 | $1.3B | $20.5B | ||
| Q4 24 | — | $20.8B | ||
| Q3 24 | — | $20.9B | ||
| Q2 24 | $1.3B | $20.7B |
负债/权益比
HCM
WSFS
| Q1 26 | — | — | ||
| Q4 25 | 0.08× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.08× | — | ||
| Q1 25 | 0.11× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.11× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $8.2M | — |
| 自由现金流经营现金流 - 资本支出 | $3.4M | — |
| 自由现金流率自由现金流/营收 | 1.2% | — |
| 资本支出强度资本支出/营收 | 1.8% | — |
| 现金转化率经营现金流/净利润 | 4.21× | — |
| 过去12个月自由现金流最近4个季度 | $-96.2M | — |
8季度趋势,按日历期对齐
经营现金流
HCM
WSFS
| Q1 26 | — | — | ||
| Q4 25 | $8.2M | $220.0M | ||
| Q3 25 | — | $121.5M | ||
| Q2 25 | $-72.9M | $37.2M | ||
| Q1 25 | $40.3M | $8.7M | ||
| Q4 24 | — | $219.9M | ||
| Q3 24 | — | $3.1M | ||
| Q2 24 | $-39.8M | $44.8M |
自由现金流
HCM
WSFS
| Q1 26 | — | — | ||
| Q4 25 | $3.4M | $213.6M | ||
| Q3 25 | — | $120.3M | ||
| Q2 25 | $-82.2M | $35.2M | ||
| Q1 25 | $32.5M | $6.3M | ||
| Q4 24 | — | $205.6M | ||
| Q3 24 | — | $-489.0K | ||
| Q2 24 | $-49.9M | $42.1M |
自由现金流率
HCM
WSFS
| Q1 26 | — | — | ||
| Q4 25 | 1.2% | 78.6% | ||
| Q3 25 | — | 44.5% | ||
| Q2 25 | -29.6% | 13.2% | ||
| Q1 25 | 10.0% | 2.5% | ||
| Q4 24 | — | 78.6% | ||
| Q3 24 | — | -0.2% | ||
| Q2 24 | -16.3% | 15.8% |
资本支出强度
HCM
WSFS
| Q1 26 | — | — | ||
| Q4 25 | 1.8% | 2.3% | ||
| Q3 25 | — | 0.5% | ||
| Q2 25 | 3.3% | 0.7% | ||
| Q1 25 | 2.4% | 0.9% | ||
| Q4 24 | — | 5.5% | ||
| Q3 24 | — | 1.4% | ||
| Q2 24 | 3.3% | 1.0% |
现金转化率
HCM
WSFS
| Q1 26 | — | — | ||
| Q4 25 | 4.21× | 3.03× | ||
| Q3 25 | — | 1.59× | ||
| Q2 25 | -0.16× | 0.51× | ||
| Q1 25 | 3.38× | 0.13× | ||
| Q4 24 | — | 3.43× | ||
| Q3 24 | — | 0.05× | ||
| Q2 24 | -1.54× | 0.65× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图